Zimmer Cites Lack Of Hip Resurfacing System As Drag On Growth
This article was originally published in The Gray Sheet
Executive Summary
Zimmer's sales of total artificial hips are being constrained by competition from less invasive hip resurfacing procedures, while knee sales are being pinched by slower-than-expected adoption of the Gender Solutions knee, the firm says
You may also be interested in...
Zimmer Stock Gains On Ortho Procedure Volume; S&N Also Up – Index
Orthopedic implant maker Zimmer's stock is benefiting in part from a recent boost in reconstructive implant procedure volumes and investor optimism for 2008-09
Zimmer Stock Gains On Ortho Procedure Volume; S&N Also Up – Index
Orthopedic implant maker Zimmer's stock is benefiting in part from a recent boost in reconstructive implant procedure volumes and investor optimism for 2008-09
Hospital Suppliers Show Vigor In ’07, With Prospects Strong For ’08 – Index
Baxter and Becton Dickinson were among large-cap hospital supply firms to prove that boring can be beautiful in 2007, as med-tech investors turned off by volatility in the sexier cardiac implant sector turned on to the relative stability of diversified, low-risk hospital products with respectable growth